Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Leptomeningeal Metastasis|Leptomeningeal Disease|HER2-positive Metastatic Breast Cancer
Interventions: DRUG: Tucatinib Oral Tablet|DRUG: Capecitabine tablets|DRUG: Trastuzumab Injection
Sponsor: UNICANCER
Collaborators: Seagen Inc.